Grifols
Why Robinhood?
You can watch Grifols and buy or sell other stocks, ETFs, and their options commission-free!About GRFS
Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others.
GRFS Key Statistics
Stock Snapshot
The current Grifols(GRFS) stock price is $9.14, with a market capitalization of 7.89B. The stock trades at a price-to-earnings (P/E) ratio of 14.88 and offers a dividend yield of 1.6%.
During the trading session on 2025-12-14, Grifols(GRFS) shares reached a daily high of $9.22 and a low of $9.10. At a current price of $9.14, the stock is +0.5% higher than the low and still -0.9% under the high.
Trading activity shows a volume of 955.6K, compared to an average daily volume of 694.62K.
The stock's 52-week range extends from a low of $6.19 to a high of $11.14.
The stock's 52-week range extends from a low of $6.19 to a high of $11.14.
GRFS News
JPMorgan lowered the firm’s price target on Grifols (GRFS) to EUR 8.50 from EUR 9 and keeps a Neutral rating on the shares. TipRanks Cyber Monday Sale Claim 6...